EMA to consult children when reviewing paediatric medicines
Consultation launched on how best to obtain views of young people
Read More
Section: Regulatory
FDA urged to give biosimilar medicines distinct scientific names
Alliance for Safe Biologic Medicines highlights safety concerns if different products have same name
Read More
EMA’s Stella Blackburn appointed president of International Society for Pharmacoepidemiology
Will continue as Agency’s risk management development and scientific lead
Read More
MHRA’s Dr June Raine to chair new EMA pharmacovigilance committee
Pharmacovigilance Risk Assessment Committee (PRAC) will lead implementation of reforms
Read MoreFDA sued for approving high dose of Eisai’s Alzheimer’s drug Aricept
Consumer rights group Public Citizen claims the high-strength dose is unsafe
Read More